Sign in
4

Changes in Ownership

Aprea Therapeutics, Inc. Filed Acc 0001104659-23-095017

Director acquired 500 shares (grant or award)

  • Director acquired 4,021,300 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Duey Marc Director 2022-08-23 Conversion +4,009,690 4,167,589 D: show line 1 in the form
Duey Marc Director 2023-08-23 Grant or award +500 208,878 D: show line 2 in the form
Duey Marc Director 2022-08-23 Conversion +11,610 602 I: show line 3 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Duey Marc Director 2022-08-23 Conversion · Series A Non-Voting Convertible Preferred Stock −400,969 0 D: show line 4 in the form
Duey Marc Director 2022-08-23 Conversion · Series A Non-Voting Convertible Preferred Stock −1,161 0 I: show line 5 in the form
Duey Marc Director 2023-08-23 Grant or award · Stock Options (Right to Buy) +2,000 2,000 D: show line 6 in the form
Loading xslF345X05/tm2324788-4_4seq1.xml…